Kyle Bradford is a Managing Partner and Co-Founder of Latticework Capital Management, LLC (“LCM”). Mr. Bradford is a member of the LCM Investment Committee and is responsible for originating, executing and managing investments in middle-market companies across a variety of industry sectors, including pharmaceutical services, medical tools and instruments and healthcare services. He is currently a member of the Board of Directors of American Veterinary Group, Restoration Behavioral Health Group, and Xpress Wellness.
Mr. Bradford was previously a Managing Director and Co-Head of the Healthcare Private Equity Group at American Capital, Ltd., a publicly traded investment company with ~$21 billion of assets under management. During his tenure at American Capital, Mr. Bradford served as chairman of American Capital portfolio companies CML Pharmaceuticals, ECA Medical and Value Plastics and served on the Board of Directors of The Meadows, Scientific Protein Laboratories, Dynojet, Hospitality Mints, Future Food and Unwired Technology. Mr. Bradford was a Board Observer for Trinity Hospice and CCS Medical.
Prior to joining American Capital, Mr. Bradford worked in the Technology Investment Banking Division of Salomon Smith Barney in New York. At Salomon, Mr. Bradford specialized in equity and debt underwriting and merger and acquisition advisory assignments for companies in various technology sectors. Before Salomon, he worked in the Syndicated Finance Group of Banc of America Securities in New York. Mr. Bradford received a Master in Professional Accounting and a Bachelors of Business Administration from the University of Texas at Austin. He is currently on the Advisory Board of the College of Pharmacy at the University of Texas at Austin and the Board of Visitors at the University of Texas Southwestern Medical Center.